Search
Displaying 1 - 10 of 53104 results for
QPP_COVID_SHMsummary
QPP Summary
SHM Buprenorphine Deregulation 2019 - Statement.pdf
The Society of Hospital Medicine supports the deregulation of buprenorphine to treat opioid use disorder. Buprenorphine is currently a Schedule III controlled substance but has restrictions
SHM Legislative Update - Summer 2019.pdf
Read SHM's Summer 2019 Grassroots Newsletter. Topics include: the Fairness for Highly Skilled Immigrants Act, the Conrad State 30 Re-authorization Act, the Mainstreaming Addiction Treatment Act,